Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Fibronectin-Binding Protein Gene Recombination and Horizontal Transfer between Group A and G Streptococci

Rebecca J. Towers, Daniel Gal, David McMillan, Kadaba S. Sriprakash, Bart J. Currie, Mark J. Walker, Gursharan S. Chhatwal, Peter K. Fagan
Rebecca J. Towers
1Menzies School of Health Research
2Institute of Advanced Studies, Charles Darwin University, Darwin, Northern Territory
3Department of Biological Sciences, University of Wollongong, Wollongong, New South Wales
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Gal
1Menzies School of Health Research
2Institute of Advanced Studies, Charles Darwin University, Darwin, Northern Territory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David McMillan
4Queensland Institute of Medical Research, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kadaba S. Sriprakash
4Queensland Institute of Medical Research, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart J. Currie
1Menzies School of Health Research
2Institute of Advanced Studies, Charles Darwin University, Darwin, Northern Territory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Walker
3Department of Biological Sciences, University of Wollongong, Wollongong, New South Wales
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gursharan S. Chhatwal
5German National Research Centre for Biotechnology, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter K. Fagan
1Menzies School of Health Research
2Institute of Advanced Studies, Charles Darwin University, Darwin, Northern Territory
6Cooperative Research Centre for Aboriginal Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: peterf@menzies.edu.au
DOI: 10.1128/JCM.42.11.5357-5361.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We report evidence of interspecies gene transfer between the important virulence factor genes sfbI and gfbA. Because the identified group G streptococcus gfbA types possess DNA cassettes that can be identified in a number of group A streptococcus strains, it appears that homologous recombination is occurring between these species.

Group A streptococcus (GAS) is a human-specific pathogen primarily infecting the throat and skin. Group G streptococcus (GGS) is generally regarded as a less important organism, which cohabits with GAS at the same tissue sites. However, some GGS, specifically Streptococcus dysgalactiae subsp. equisimilis, are capable of causing serious and life-threatening diseases traditionally associated with GAS (1, 4, 9, 20, 28). These diseases include septicemia (10), endocarditis (25), septic arthritis (12), pneumonia, meningitis, pharyngitis, otitis media, acute poststreptococcal glomerulonephritis (22), and cellulitis (7). Although no definitive cases of GGS-associated acute rheumatic fever have been reported, antibodies raised against Australian GGS strains have recently been shown to cross-react with human heart muscle myosin, which has reported to indicate a potential to elicit an autoimmune response that may trigger acute rheumatic fever (13).

Identification of genes encoding C5a peptidase, M protein (emm) (5, 24, 26), streptococcal pyrogenic exotoxin G (SpeG) (23), streptolysin O, and streptokinase in GGS is consistent with the observation that these two bacteria have a common disease spectrum. Sequence analysis of these genes from various S. dysgalactiae subsp. equisimilis isolates suggested that horizontal genetic transfer between GAS and GGS may have contributed to the diversity of these genes. More recently, multilocus sequence typing revealed that horizontal acquisition may also have contributed to variations in selection-neutral housekeeping genes in GGS (16). The multilocus sequence typing data also suggests that the overall direction of genetic flow is predominantly from GAS to GGS. In order to test the generality of horizontal acquisition in contributing to diversity of virulence genes, we chose to investigate sfbI, encoding streptococcal fibronectin-binding protein I (SfbI; also known as protein F1) (14, 27).

SfbI is an important and well-characterized virulence factor in GAS that is involved in adherence to throat and skin cells (21, 27) and mediates GAS internalization in epithelial cells (15, 19). A detailed study of gene architecture of sfbI from different GAS strains revealed mosaic structures suggesting lateral genetic transfer between strains of GAS and recombination contributing to sfbI diversity (29). sfbI is situated in a chromosomal locus called the FCT region (named FCT for fibronectin, collagen binding, and T antigen) under the transcriptional regulation of RofA, which is also encoded in this region (3).

The sfbI homolog gfbA has been identified in GGS and is reportedly present in about 30% of GGS strains (17), although only one gfbA gene has been sequenced and characterized. The present study showed that approximately 10% of S. dysgalactiae subsp. equisimilis isolates from humans in the Northern Territory of Australia have the GGS sfbI homolog gfbA and that this gene is located adjacent to rofA, which is also the case in the GAS FCT locus. Comparison of derived gfbA sequences with the sequences of known sfbI genes revealed mosaicism, with sections of gfbA homologous to corresponding sections of different sfbI types.

The 38 GGS isolates used in this study were collected between 1995 and 2003 from remote Aboriginal communities in the tropical Top End of the Northern Territory, Australia, or as clinical samples from the Royal Darwin Hospital, Darwin, Northern Territory, Australia. In Aboriginal communities of the Top End, streptococcal infections are endemic (11), and the rates of poststreptococcal sequelae are among the highest in the world (6, 18). These GGS isolates are of special importance, because it has been hypothesized that pharyngeal carriage of GGS may trigger rheumatic fever in this population (13). All bacteria selected for use in this study were large colony-forming beta-hemolytic streptococci that reacted with group G-specific antisera (Oxoid, Basingstoke, England). They were identified as S. dysgalactiae subsp. equisimilis using commercially available gram-positive identification test cards in a VITEK system (BioMerieux, Durham, N.C.). PCR screening of GGS isolates for gfbA and rofA and DNA sequence analysis were performed as described previously (29) using the same primer sets (Table 1) and PCR parameters.

View this table:
  • View inline
  • View popup
TABLE 1.

Primer sequences used to detect gfbA and rofA in GGSa

The entire gfbA gene was present in 4 of the 38 GGS isolates designated 59G, NS3402, NS3404, and NS3404 (Fig. 1). Size variation in the length of gfbA (Fig. 1A) was attributed to either differences in the numbers of fibronectin-binding repeats or recombination within the proline-rich domain. All four GGS gfbA genes identified in this study were adjacent to the gene encoding the global regulator RofA (Fig. 1B). In fact, the presence of rofA was detected in all of the 38 GGS strains tested (results not shown). RofA is a global regulator of GAS (8) found in the FCT region, a locus which exhibits high rates of recombination (3). Therefore, it is possible that an analogous FCT region under the control of RofA is present in all human S. dysgalactiae subsp. equisimilis strains and that horizontal transfer from GAS could incorporate genes into this recombinatorial hot spot. Further investigation of the downstream genes is necessary to elucidate whether this region of the GGS chromosome is truly homologous with the GAS FCT region. However, finding this regulator adjacent to gfbA does suggest an analogous regulatory mechanism influencing bacterial persistence and virulence factor expression in S. dysgalactiae subsp. equisimilis. Furthermore, other virulence determi-nant genes that are influenced by RofA in GAS have been detected in human GGS isolates (2, 24, 30).

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Ethidium bromide-stained 1% agarose gels showing the results of PCR screening for gfbA and rofA in S. dysgalactiae subsp. equisimilis isolates. (A) Screening for full-length gfbA. Variations in the amplified product are due to differences in the numbers of fibronectin-binding and proline-rich repeats and the type of proline-rich region present. (B) Screening for the presence of rofA adjacent to gfbA. Lanes 1 to 5 contain GeneRuler 100-bp ladder (MBI Fermentas), GGS 59G, GGS NS3402, NS3404, and NS3404, respectively.

Partial sequence from the variable 5′ end of gfbA (Fig. 2A) and the published gfbA sequence (accession number U31115 ) (17) were compared with previously reported sfbI sequences from GAS. Overall, the architectural arrangements of predicted GfbA proteins are the same as that of SfbI (Fig. 2). From the N to C terminus, the proteins include a signal sequence, an aromatic amino acid-rich domain (Aro domain), a proline-rich domain comprising a proline-rich region (Pro region) and several proline-rich repeats, an upstream fibronectin-binding domain, a fibronectin-binding repeat region, and an anchor. The C-proximal half beginning with the proline-rich repeats is highly conserved and differs primarily in the number of repeats, but the N-proximal Aro and Pro domains are highly variable. In GAS, 15 Aro domain sequence types (Aro types) and 2 Pro region sequence types (ProA and ProB) were identified.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Variation seen in the sfbI/gfbA gene family in GAS and GGS. (A) Schematic showing the range of percentage DNA identity for each domain (above) and for each section of the aromatic amino acid-rich domain (below). Gaps introduced to aid alignment have been treated as single base changes. The diagram is not drawn to scale. The lower schematic defines DNA cassettes or sections used to illustrate the gene mosaic structure of sfbI/gfbA. UFBD, upstream fibronectin-binding domain; Fn-binding repeats, fibronectin-binding repeats. (B) Analysis demonstrating similarity between DNA cassettes found in sfbI and gfbA. Sections 1 to 4 correspond to the region encoding the aromatic amino acid-rich domain (described in the text). Section 5 corresponds to the proline-rich region type (ProA/ProB). Sections with the greatest percent identity to the corresponding sfbI Aro types in pairwise comparison are shown in bold type. GAS strain BL16 is an example used to demonstrate the analogous mosaic arrangement in GAS which has been previously described (29). Aro16 ProB1 was determined by analyzing the previously characterized gfbA from GGS strain 1750 (16).

The five gfbA sequences were aligned against the previously described GAS sfbI sequences. The alignment revealed four gfbA types (ST35 to ST38) with three novel Aro types in GGS (Aro16 to Aro18). Similar to sfbI in GAS, the gfbA gene in GGS exhibits a mosaic structure within the Aro domain. To better illustrate this structure, the Aro domain has been divided into four main sections (Fig. 2A). These sections represent distinct DNA cassettes with local homology between Aro types, which lie between highly conserved “junction” sequences. For instance, in GGS 1750, the Aro domain sections 1, 2, 3, and 4 may have evolved from GAS Aro5, Aro6, Aro6, and Aro5, respectively. Likewise, sections 1 to 4 in GGS 59G appear to have been derived from GAS Aro1, Aro2 or Aro4, Aro2, and Aro3, respectively (Fig. 2B).

Three of the GGS isolates contain Aro18 gfbA genes. Two of the three isolates are clonal (NS3402 and NS3404) as determined by random amplification of polymorphic DNA and pulsed-field gel electrophoretic analysis. NS3572 is not clonal, although the pulsed-field gel electrophoresis fingerprint indicates a limited degree of shared loci (results not shown). This Aro type (Aro18) has evolved from mosaic arrangements. Aro domain sections 1, 3, and 4 have evolved from GAS Aro4, a novel Aro type, Aro6, and Aro8, respectively. Comparing NS3572 to NS3404, there are five base changes in the Aro-rich domain, only two of which are silent. Further differences are apparent in the proline-rich repeats with NS3404 having three nonidentical repeats. In contrast, NS3572 contains a single proline-rich repeat, which is identical to those seen in some GAS strains. These differences can be explained by accumulations of point mutations and duplication or deletion events within the genome. These differences can also be explained, however, by ongoing interspecies lateral transfer rearranging mosaic cassettes. It is not possible from these data to determine whether recombinational diversification is occurring in GAS prior to horizontal transfer or whether it is ongoing within GGS. A majority of the mosaic cassettes have been identified in GAS isolates which cohabit with S. dysgalactiae subsp. equisimilis. When the GGS aromatic-rich domain gene sequences are aligned against the known GAS aromatic-rich domain gene sequences using pairwise comparisons, the different GGS-derived Aro types group among GAS isolates. In fact, there is very little similarity between the GGS sequences (54.3 to 67.3% in pairwise analysis). This observation, in light of the fact that the GGS sequences show less similarity between themselves than with the homologous GAS sequences, supports the hypothesis that it is unlikely that the differences seen are the result of intragenomic or intergenomic rearrangement with other GGS.

This study is the first demonstration that ongoing lateral transfer leading to genetic diversity may extend to a streptococcal virulence gene with limited strain distribution and that there is ongoing mosaic rearrangement within the sfbI/gfbA gene family in GAS or GGS. This horizontal gene transfer and gene rearrangement are of particular significance in light of the fact that the regulatory genes involved in the control of these pathogenicity factors (i.e., rofA) have also been identified in S. dysgalactiae subsp. equisimilis. We believe that taken together, these results indicate that selective pressure may result in the emergence of virulent human pathogenic GGS strains with the potential to cause diseases classically associated with GAS.

Nucleotide sequence accession numbers.

All newly determined nucleotide sequences were deposited in GenBank The nucleotide sequences and accession numbers follow: GGS isolate 59G (ST36), AJ605760 ; GGS isolate NS3402 (ST37), AJ605743 ; GGS isolate NS3404 (ST37), AJ605744 ; and GGS isolate NS3572 (ST38), AJ605745 . The alignment of the GGS gfbA variable regions with published GAS sfbI Aro types may be accessed through the EMBL nucleotide database (Align_000635).

ACKNOWLEDGMENTS

This work was supported in part by the Cooperative Research Centre for Aboriginal Health (Australia), the National Health and Medical Research Council of Australia, and the BMBF Network “Pathogenomik” (Germany). P.K.F. is the recipient of an Alexander von Humboldt Foundation Fellowship.

We thank M. McDonald and P. Dasari for their contributions to the MSHR Northern Territory Streptococcal Collection, the source of the strains mentioned in this paper.

FOOTNOTES

    • Received 20 April 2004.
    • Returned for modification 8 June 2004.
    • Accepted 30 July 2004.
  • Copyright © 2004 American Society for Microbiology

REFERENCES

  1. 1.↵
    Barnham, M. 1983. The gut as a source of the haemolytic streptococci causing infection in surgery of the intestinal and biliary tracts. J. Infect.6:129-139.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Beckert, S., B. Kreikemeyer, and A. Podbielski. 2001. Group A streptococcal rofA gene is involved in the control of several virulence factor genes and eukaryotic cell attachment and internalization. Infect. Immun.69:534-537.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Bessen, D. E., and A. Kalia. 2002. Genomic localization of a T serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infect. Immun.70:1159-1167.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Christensen, K. K., P. Christensen, L. Flamholc, and T. Ripa. 1974. Frequencies of streptococci of groups A, B, C, D, and G in urethra and cervix swab specimens from patients with suspected gonococcal infection. Acta Pathol. Microbiol. Scand. Sect. B82:470-474.
    OpenUrl
  5. 5.↵
    Collins, C. M., A. Kimura, and A. L. Bisno. 1991. Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci. Infect. Immun.60:3689-3696.
    OpenUrl
  6. 6.↵
    Currie, B. 1993. Medicine in tropical Australia. Med. J. Aust.158:609, 612-615.
    OpenUrlPubMedWeb of Science
  7. 7.↵
    Efstratiou, A. 1997. Pyogenic streptococci of Lancefield groups C and G as pathogens in man. Soc. Appl. Bacteriol. Symp. Ser.26:72S-79S.
    OpenUrlPubMed
  8. 8.↵
    Fogg, G. C., C. M. Gibson, and M. G. Caparon. 1994. The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes. Mol. Microbiol.11:671-684.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Forrer, C. B., and P. D. Ellner. 1979. Distribution of hemolytic streptococci in respiratory specimens. J. Clin. Microbiol.10:69-71.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Galloway, A., I. Noel, A. Efstratiou, E. Saint, and D. R. White. 1994. An outbreak of group C streptococcal infection in a maternity unit. J. Hosp. Infect.28:31-37.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Gardiner, D. L., and K. S. Sriprakash. 1996. Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia. J. Clin. Microbiol.34:1448-1452.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Gaunt, P. N., and D. V. Seal. 1987. Group G streptococcal infections. J. Infect.15:5-20.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Haidan, A., S. R. Talay, M. Rohde, K. S. Sriprakash, B. J. Currie, and G. S. Chhatwal. 2000. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet356:1167-1169.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Hanski, E., and M. Caparon. 1992. Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA89:6172-6176.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Jadoun, J., V. Ozeri, E. Burstein, E. Skutelsky, E. Hanski, and S. Sela. 1998. Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. J. Infect. Dis.178:147-158.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Kalia, A., M. C. Enright, B. G. Spratt, and D. E. Bessen. 2001. Directional gene movement from human-pathogenic to commensal-like streptococci. Infect. Immun.69:4858-4869.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Kline, J. B., S. Xu, A. L. Bisno, and C. M. Collins. 1996. Identification of a fibronectin-binding protein (GfbA) in pathogenic group G streptococci. Infect. Immun.64:2122-2129.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    MacDonald, K. T., and A. C. Walker. 1989. Rheumatic heart disease in aboriginal children in the Northern Territory. Med. J. Aust.150:503-505.
    OpenUrlPubMed
  19. 19.↵
    Molinari, G., S. R. Talay, P. Valentin-Weigand, M. Rohde, and G. S. Chhatwal. 1997. The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect. Immun.65:1357-1363.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Nunthapisud, P., S. Sililertpanrana, K. Tatiyakavee, and S. Chumdermpadetsuk. 1990. Occurrence of beta-hemolytic streptococcus group G in school children and sick children. Southeast Asian J. Trop. Med. Public Health21:215-218.
    OpenUrlPubMed
  21. 21.↵
    Okada, N., A. P. Pentland, P. Falk, and M. G. Caparon. 1994. M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J. Clin. Investig.94:965-977.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Reid, H. F., D. C. Bassett, E. Gaworzewska, G. Colman, and T. Poon-King. 1990. Streptococcal serotypes newly associated with epidemic post-streptococcal acute glomerulonephritis. J. Med. Microbiol.32:111-114.
    OpenUrlCrossRefPubMed
  23. 23.↵
    Sachse, S., P. Seidel, D. Gerlach, E. Gunther, J. Rodel, E. Straube, and K. H. Schmidt. 2002. Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp. equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speGdys). FEMS Immunol. Med. Microbiol.34:159-167.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    Schnitzler, N., A. Podbielski, G. Baumgarten, M. Mignon, and A. Kaufhold. 1995. M or M-like protein gene polymorphisms in human group G streptococci. J. Clin. Microbiol.33:356-363.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    Smyth, E. G., A. P. Pallett, and R. N. Davidson. 1988. Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J. Infect.16:169-176.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Sriprakash, K. S., and J. Hartas. 1996. Lateral genetic transfers between group A and G streptococci for M-like genes are ongoing. Microb. Pathog.20:275-285.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Talay, S. R., P. Valentin-Weigand, P. G. Jerlstrom, K. N. Timmis, and G. S. Chhatwal. 1992. Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect. Immun.60:3837-3844.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Teare, E. L., R. D. Smithson, A. Efstratiou, W. R. Devenish, and N. D. Noah. 1989. An outbreak of puerperal fever caused by group C streptococci. J. Hosp. Infect.13:337-347.
    OpenUrlCrossRefPubMed
  29. 29.↵
    Towers, R. J., P. K. Fagan, S. R. Talay, B. J. Currie, K. S. Sriprakash, M. J. Walker, and G. S. Chhatwal. 2003. Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure. J. Clin. Microbiol.41:5398-5406.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    Woo, P. C., J. L. Teng, S. K. Lau, P. N. Lum, K. L. Leung, K. L. Wong, K. W. Li, K. C. Lam, and K. Y. Yuen. 2003. Analysis of a viridans group strain reveals a case of bacteremia due to Lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp. equisimilis in a patient with pyomyositis and reactive arthritis. J. Clin. Microbiol.41:613-618.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Fibronectin-Binding Protein Gene Recombination and Horizontal Transfer between Group A and G Streptococci
Rebecca J. Towers, Daniel Gal, David McMillan, Kadaba S. Sriprakash, Bart J. Currie, Mark J. Walker, Gursharan S. Chhatwal, Peter K. Fagan
Journal of Clinical Microbiology Nov 2004, 42 (11) 5357-5361; DOI: 10.1128/JCM.42.11.5357-5361.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Fibronectin-Binding Protein Gene Recombination and Horizontal Transfer between Group A and G Streptococci
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Fibronectin-Binding Protein Gene Recombination and Horizontal Transfer between Group A and G Streptococci
Rebecca J. Towers, Daniel Gal, David McMillan, Kadaba S. Sriprakash, Bart J. Currie, Mark J. Walker, Gursharan S. Chhatwal, Peter K. Fagan
Journal of Clinical Microbiology Nov 2004, 42 (11) 5357-5361; DOI: 10.1128/JCM.42.11.5357-5361.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Nucleotide sequence accession numbers.
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Adhesins, Bacterial
Fibronectins
Gene Transfer, Horizontal
Recombination, Genetic
streptococcus
Streptococcus pyogenes

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X